Loading...
Loading...
Indianapolis runs the deepest predictive analytics market in Indiana, and the depth comes from an unusual mix. Eli Lilly's headquarters at McCarty Street feeds pharmaceutical R&D and commercial-analytics modeling at a global scale that pulls in McKinsey, Tiger Analytics, and ZS Associates as default partners. Anthem (now Elevance Health) at Monument Circle generates payer-side risk scoring, network optimization, and SDOH modeling on a national membership base. Salesforce's regional headquarters in the old Chase Tower brings commercial AI workloads at a different cadence. IU Health and Community Health Network drive provider-side capacity and quality forecasting. The 16 Tech innovation district just north of downtown — anchored by the AnalytiXIN partnership and the Indiana Biosciences Research Institute — has become the formal connective tissue between the corporate buyers and the IU and Purdue research pipelines. The result is a market where ML engagements range from a thirty-thousand-dollar Series-B SaaS churn model to a multi-million-dollar pharmaceutical commercial analytics build, and where the right consulting partner depends almost entirely on which segment of the buyer base you actually live in. LocalAISource matches Indianapolis operators to practitioners who can read that buyer-segment topology and arrive with relevant prior work rather than generic capability slides.
Updated May 2026
Lilly drives a substantial share of Indianapolis predictive analytics work, both directly and through the consultancies that maintain Indianapolis offices specifically to serve Lilly. ZS Associates runs a major presence here, IQVIA has a significant Indianapolis footprint, and Tiger Analytics opened an Indianapolis location specifically to be near Lilly's commercial analytics decision-makers. The work itself spans three families. Commercial analytics — physician targeting, sales force sizing, marketing-mix modeling, next-best-action engines — runs on Lilly's Snowflake and Databricks footprint with model outputs feeding Veeva CRM and the Adobe marketing stack. Real-world evidence and HEOR analytics — outcomes modeling, propensity-score matching on claims data, comparative effectiveness — run on a separate analytics environment with strict data governance. R&D-side ML — translational analytics, clinical trial enrollment forecasting, biomarker discovery — runs inside the Lilly Research Laboratories environment with even tighter access controls. Engagement scope on direct Lilly work typically runs into seven figures over twelve to eighteen months, and the consulting partner bench is dominated by ZS, IQVIA, and Tiger plus a handful of specialized boutiques. Smaller Indianapolis pharma and biotech buyers — Eskenazi, Roche Diagnostics' Indianapolis operation, and the IBRI portfolio — run engagements at smaller scale but with the same governance expectations.
Elevance Health (Anthem) at Monument Circle runs one of the largest payer-side ML operations in the country, with internal teams and a long-running set of consulting relationships dominating most of the work. The engagement profile centers on risk adjustment modeling, network optimization, social-determinants-of-health scoring, and fraud-waste-and-abuse detection, with model outputs feeding claims-processing and care-management platforms. The provider side — IU Health from its University Hospital and Methodist Hospital footprint, Community Health Network across its east-side facilities, Eskenazi Health on the near west side — runs the more familiar capacity, readmission, and revenue-cycle prediction work on Epic and Cerner footprints. The interesting Indianapolis-specific dynamic is the increasing collaboration between payer and provider ML teams through value-based care arrangements, which produces shared modeling work on patient attribution, total-cost-of-care prediction, and quality-measure forecasting. A consulting partner working in this segment needs fluency in both payer claims data and provider EHR data and an honest perspective on the political dynamics of value-based care contracts. Engagement scope here typically runs sixteen to thirty-two weeks and lands in the one-fifty to four-hundred-thousand-dollar range for a serious value-based-care modeling engagement. The smaller community-hospital and physician-group engagements price more like the Bloomington or Fort Wayne range.
The 16 Tech innovation district has become the connective tissue for Indianapolis predictive analytics work outside the largest corporate buyers. AnalytiXIN, the partnership funded by Lilly, Eli Lilly Foundation, IU, and the state, runs faculty fellowships and corporate engagements that pull IU and Purdue research talent into specific industry problems. The Indiana Biosciences Research Institute occupies a building in the district and pulls life sciences ML work that is not core enough for Lilly to do in-house. The Indiana University School of Medicine's data science programs and the Regenstrief Institute on West 10th Street feed a steady supply of clinical-informatics ML talent. For mid-market Indianapolis buyers — companies with revenue between fifty million and a billion that cannot afford a McKinsey engagement but need more than a junior data scientist — the AnalytiXIN and 16 Tech ecosystem provides a structured path to consulting partners that the Carmel or Fishers ecosystems do not match. Engagement pricing for mid-market buyers in this segment runs sixty to two-hundred-thousand dollars over eight to twenty weeks, with the AnalytiXIN affiliation often providing access to faculty time at preferential rates. A capable consulting partner will know how to plug into AnalytiXIN rather than pretending the resource does not exist.
For most mid-market buyers, boutique partners produce better outcomes at materially lower cost. ZS and IQVIA are calibrated to serve enterprise pharmaceutical and life-sciences clients at a scale where their pricing and engagement model fit. A fifty-million-dollar revenue Indianapolis manufacturer trying to engage either firm will get a junior team and a pricing structure mismatched to the actual work. The exception is when the buyer is a Lilly supplier or partner and the engagement is being co-funded, in which case the alignment improves. For independent mid-market work, look at the boutiques in the 16 Tech ecosystem and the senior independent consultants who came out of ZS, Lilly, or Anthem and now consult independently.
Three concrete ways. First, faculty fellowships allow a corporate sponsor to embed an IU or Purdue faculty member into a problem for a defined period, typically a semester or summer, at materially below market rates for the equivalent senior consulting time. Second, AnalytiXIN-funded graduate students can be staffed onto sponsored projects, providing junior data science capacity at a cost structure unavailable to a typical consulting engagement. Third, the affiliation produces a bridge to research expertise that pure consulting firms cannot match, particularly in life sciences and healthcare. A capable consulting partner working in Indianapolis will scope these options into the engagement plan rather than treating them as an afterthought.
Deeper than any other Indiana metro and competitive with mid-tier national markets. Senior ML engineers in Indianapolis come out of Lilly, Anthem, Salesforce, IU Health, and the regional consulting offices, with compensation expectations ten to fifteen percent below Chicago and roughly equal to Minneapolis. The 16 Tech and Mass Ave talent pools are strong on commercial and product analytics; the Lilly alumni network is strong on pharmaceutical and life-sciences ML; the Anthem alumni network is strong on payer and risk-adjustment work. A consulting partner staffing an Indianapolis engagement should be able to articulate which of those alumni pools the senior talent on the engagement is drawn from, since the fit varies meaningfully by buyer industry.
Lilly runs both, with Snowflake for commercial and operational analytics and Databricks for R&D and data-science workloads. Anthem runs heavily on a mix of on-premises Hadoop legacy plus Azure Synapse and Databricks for newer work. IU Health and Community Health both lean Snowflake with smaller Databricks footprints for specialized workloads. The mid-market Indianapolis buyer base splits roughly evenly. A consulting partner who arrives with a strong default opinion about one platform versus the other is signaling that they have not actually read the buyer's existing footprint. The right answer is almost always to use what the buyer already runs and not push a platform migration as part of an ML engagement.
Ask five. First, what specific Indianapolis case studies does the partner have, and what was the actual production outcome — not the proof-of-concept outcome — six months after handoff. Second, who on the proposed team is from the relevant alumni pool for the buyer's industry; Lilly alumni for pharma, Anthem alumni for payer work, Lilly or Roche alumni for diagnostics. Third, does the partner have current AnalytiXIN affiliation or active relationships with IU or Purdue ML faculty. Fourth, what is the partner's experience with the buyer's specific data warehouse and ML platform, with concrete production examples not just certifications. Fifth, who at the partner firm actually lives in Indianapolis versus parachuting in from Chicago or New York.
Get found by Indianapolis, IN businesses searching for AI expertise.
Join LocalAISource